Serum creatinine recognized 12% and serum cystatin C identified 40% of type 2 diabetic patients with nephropathy [48], while in another study, serum cystatin C discriminated between normoalbuminuria and microalbuminuria in type 2 diabetic patients [49]. This evidence concerns the gene CST3 and kidney disorder.